TGF-beta/Smad
特异性亚型抑制剂
TGF-beta/Smad产品
目录号 | 产品描述 | 文献引用 | 实验数据 |
---|---|---|---|
S1067 |
SB431542SB431542是一种有效的,选择性ALK5抑制剂,无细胞试验中IC50为94 nM,对ALK5的作用比对p38、MAPK和其他激酶强100倍。 |
![]() ![]() Long-term response of SB431542 and SB203580 release from scaffold implants. Histological results of H&E staining showing the capsule thickness of the various treatments at 14 days. The scale bar shows 100 uM and is applicable to all images in the panel. In each bar graph the tissue and cellular response to SB431542 were found to be significant from the control. For each treatment group six animals were tested. Statistics are performed by ANOVA with Bonferroni comparisons and taken to be significant at ∗∗P < 0.01. |
|
S2618 |
LDN-193189LDN-193189 (DM3189)是一种选择性 BMP 信号抑制剂,抑制 ALK1, ALK2, ALK3和 ALK6,在激酶测定中的 IC50 分别为 0.8 nM、0.8 nM、5.3 nM 和 16.7 nM。LDN-193189 抑制BMP I型受体ALK2和ALK3的转录活性,在C2C12细胞中IC50分别为5 nM和30 nM,作用于BMP比作用于TGF-β选择性高200倍。如需进行动物实验,建议选择可水溶产品 S7507 LDN-193189 2HCl。 |
![]() ![]() LDN induces signifiant cell death. OVCA429 cells were treated with vehicle (DMSO) or experimental drugs for 6 hr to capture different stages of cell death. OVCA429 cell viability was assessed in response to drug treatment for 6 hr by staining with AO (green) and EB (orange). For clarity the different fluorescent channels to detect AO, EB, and the over-lapping images are shown for 10 mM LDN treatment. |
|
S2230 |
Galunisertib (LY2157299)Galunisertib (LY2157299)是有效的TGFβ receptor I (TβRI)抑制剂,无细胞试验中IC50为56 nM。Phase 2/3。 |
![]() ![]() Cells were treated in both formats with 10 uM of SB525334 (TGFβR1), SJN 2511 (TGFβR1), LY2157299 (TGFβR2, TGFβR1), Dorsomorphin (AMPK, ALK2, ALK3, ALK6), DMH-1 (ALK2), or GW5074 (c-raf), or 50 ng/ml of TGF-β. Microtissue or tissue-culture well fluorescence for each condition are shown after 3 days of culture for 393T5 cells, which proliferate slower in control conditions, so that the two cell lines undergo the same number of population doublings during each assay. |
|
S2704 |
LY2109761LY2109761是一种新型的,选择性TGF-β receptor type I/II (TβRI/II)双重抑制剂,无细胞试验中Ki分别为38 nM和300 nM,对Smad2的磷酸化产生负面影响。LY2109761可抑制自噬而诱导凋亡。 |
![]() ![]() The inhibition of TGF-β1 signaling pathways suppressed EBV-mediated EMT, and prevented the activation of Syk and Src signaling. The EBV-infected HCECs were treated with 100 nM of the dual TGF-β receptor I and II kinase inhibitor, LY2109761, for 48 hours. The EBV-infected HCECs were cultured with anti-TGF-β1 neutralizing antibody (5 ug/mL) or mouse IgG1 antibody (5 ug/mL) for 48 hours. Photographs were taken at x100 magnification by a digital camera.
|
|
S1476 |
SB525334SB525334是一种有效的,选择性TGFβ receptor I (ALK5)抑制剂,无细胞试验中IC50为14.3 nM,作用于ALK4比作用于ALK5效果低4倍,对ALK2,3,和 6没有活性。 |
![]() ![]() LS 174T and SW480 cells were treated with SB525334 (1 umol/L) for 12 hours. HMGA2 expression was assessed by immunoblotting. Each experiment was repeated 3 times. Bars, SD; *, P < 0.05; **, P < 0.01.
|
|
S2186 |
SB505124SB505124是一种选择性TGFβR抑制剂,作用于ALK4和ALK5,无细胞试验中IC50分别为129 nM和47 nM,也抑制ALK7,但不抑制ALK1,2,3或6。 |
![]() ![]() (D): Fluorescence micrographs of SOX2/FOXA2 double-staining of the conditions mentioned above. The TGF-b inhibitor SB-505124 (1 mM) was additionally used together with the complete medium. Nuclei were counterstained with DAPI. Original magnification 310 or 340. Abbreviations: DAPI, 40,6-diamidino-2-phenylindole; RA, retinoic acid.
|
|
S7306 |
Dorsomorphin (Compound C) 2HClDorsomorphin 2HCl (BML-275, Compound C) 是一种有效的,可逆的,选择性AMPK抑制剂,在无细胞试验中Ki为109 nM,对一些结构相关的激酶,包括ZAPK, SYK, PKCθ,PKA和JAK3没有显著的抑制作用。也会抑制I型BMP受体。Dorsomorphin 可诱导癌细胞系的自噬。 |
![]() ![]() AMPK inhibition by compound C(Dorsomorphin) inhibited autophagy activation and neuroprotection induced by IPC in PC12 cells. (A) Compound C (Comp C) abolished IPC induced neuroprotection in PC12 cells. Cells were incubated with compound C 5 μM 60 min before the onset of IPC. Twelve hours after IPC, the cells were subjected to OGD for 10 h and cell viability was examined with CCK-8 kit. (B) Compound C reduced LC3II/LC3I ratio. The cells were incubated with compound C 5 μM 60 min before the onset of IPC. Then the cells were harvested 12 h after IPC and subjected to Western blot analysis. Bar represents mean ± SD, n = 3. *P < 0.05, ***P < 0.001 compared with the control group; $$$ P < 0.001 compared with the OGD group; %%% P < 0.001 compared with the IPC + OGD group; # P < 0.05 compared with the IPC group. |
|
S2907 |
Pirfenidone (S-7701)Pirfenidone (S-7701, AMR-69) 抑制TGF-β产生和TGF-β刺激的胶原蛋白产生,且降低TNF-α和IL-1β产生,具有抗纤维化和抗炎特性。Pirfenidone可减弱 chemokine (CC motif) ligand-2 (CCL2) 和 CCL12的生成,并具有抗纤维化的活性。Phase 3。 |
![]() ![]() Ex vivo tissue spotting experiment of pirfenidone dilutions and MalDI imagingn approach of in vivo administered pirfenidone measured with MalDI-TOF mass spectrometer. ex vivo dilution series of pirfenidone (m/z 186.2?.1 Da) covered with CHCa matrix. In vivo treated liver cryosections measured by MalDI-TOF imaging using CHCa. Size bar corresponds to 2 mm.
|
|
S2750 |
GW788388GW788388是一种有效的,选择性ALK5抑制剂,无细胞试验中IC50为18 nM,也抑制TGF-βII型受体和activin II型受体活性,但不抑制BMP II型受体。 |
![]() ![]() Combination treatment with GW788388 and IL-23 aiming to sustain Th17 cell levels increases spleen cell production of the inflammatory mediators IL-17 and TNF-a, the stimulatory mediators IL-2, IFN-g and RANTES, and the inhibitory mediator IL-10. Starting from Week 6 of 4NQO administration, when premalignant oral lesions were detectable on the tongue, mice were initiated on treatment with diluent, GW788388, IL-23 or both GW788388 and IL-23. After 2 months of these treatments, spleens were collected and cultured on anti-CD3 for 3 days. Supernatants were collected and used for measurement of the inflammatory mediators IL-17, TNF-a and IL-6 (a); stimulatory mediators IL-2, IFN-g and RANTES (b); and inhibitory mediators, TGF-b, IL-4 and IL-10 (c). *=p<0.05, **=p<0.01, ***=p<0.001.
|
|
S2805 |
LY364947LY364947 (HTS 466284)是一种有效的ATP竞争性TGFβR-I抑制剂,无细胞试验中IC50为59 nM,比作用于TGFβR-II选择性高7倍。 |
![]() ![]() The cytoplasmic and nuclear proteins were separated and the protein expression levels were determined by performing western blotting. LY364947 (1 uM), which is a potent ATP-competitive inhibitor of TGF-βRI, was used as the positive control. GAPDH and PARP were used as cytosolic and nuclear markers, respectively. |
|
S7223 |
RepSox (E-616452)RepSox (E-616452, SJN 2511, ALK5 Inhibitor II)是一种有效的,选择性TGFβR-1/ALK5抑制剂,作用于ATP与ALK5结合以及ALK5自磷酸化,无细胞试验中IC50分别为23 nM和4 nM。 |
![]() ![]() (C) Generation of pluripotent stem cell from Yamanaka factors-induced OG2-MEFs under treatment of diverse chemical compounds. Images of GFP+ colonies were taken on day 10 post-infection. VPA, 0.5 mmol/L. CHIR99021, 3 μmol/L. Repsox, 1 μmol/L. (D) Quantification of GFP+ colonies in (C). All figures are representative of three independent experiments (n = 3). All data are presented as mean ± SD. *P < 0.05, **P < 0.01 vs. DMSO
|
|
S7507 |
LDN-193189 2HClLDN-193189 (DM3189) 2HCl是一种选择性 BMP 信号抑制剂,抑制 ALK1, ALK2, ALK3和 ALK6,在激酶测定中的 IC50 分别为 0.8 nM、0.8 nM、5.3 nM 和 16.7 nM。LDN-193189 抑制BMP I型受体ALK2和ALK3的转录活性,在C2C12细胞中IC50分别为5 nM和30 nM,作用于BMP比作用于TGF-β选择性高200倍。 |
![]() ![]() LDN induces signifiant cell death. OVCA429 cells were treated with vehicle (DMSO) or experimental drugs for 6 hr to capture different stages of cell death. OVCA429 cell viability was assessed in response to drug treatment for 6 hr by staining with AO (green) and EB (orange). For clarity the different fluorescent channels to detect AO, EB, and the over-lapping images are shown for 10 mM LDN treatment.
|
|
S1576 |
Sulfasalazine (NSC 667219)Sulfasalazine (NSC 667219, Azulfidine, Salazopyrin, Sulphasalazine) 是一种磺胺剂,是Mesalazine的衍生物,主要用作抗炎剂。Sulfasalazine 是一种有效的、特异性的 nuclear factor kappa B (NF-κB)、TGF-β 和 COX-2 的抑制剂。Sulfasalazine 可诱导铁死亡、凋亡和自噬。 |
||
S7359 |
K02288K02288是一种高度选择性I型BMP受体抑制剂,针对 ALK2, ALK1和ALK6的IC50分别为1.1,1.8,6.4 nM,显示对其他ALKS(3,4,5)和的ActRIIa 有轻微抑制作用。 |
![]() ![]() A549 cells were transfected with miR-205 inhibitor (IHT-205, 100 nM). Forty hours after transfection, the cells were seeded on transwell plates and treated with or without inhibitor K02288 (10 nM), AG1478 (1 µM), SB431542 (10 µM) for 10 hours. Migrated cells were quantified. All data are shown as mean± SD. N =3. All experiments have been repeated at least 3times independently. |
|
S7624 |
SD-208SD-208是一种选择性TGF-βRI (ALK5)抑制剂,with IC50为48 nM,选择性比TGF-βRII高100多倍。 |
||
S7692 |
A-83-01A-83-01 是一种有效的 TGF-β type I receptor (ALK5-TD) 的抑制剂,其IC50值为12 nM。A-83-01 还抑制由 activin/nodal type I receptor (ALK4-TD) 和 nodal type I receptor (ALK7-TD) 诱导的转录,对应的IC50值分别为45 nM和7.5 nM。现配现用。 |
||
S0752 |
AUDAAUDA (compound 43) 是一种有效的 soluble epoxide hydrolase (sEH) 的抑制剂,对小鼠sEH和人sEH的IC50值分别为18 nM和69 nM。AUDA具有抗炎活性,可降低MMP-9、IL-1β、TNF-α 和 TGF-β。AUDA还可下调 Smad3 和 p38 信号通路。 |
||
S8700 |
TP0427736 HClTP0427736是一种有效的ALK5 kinase抑制剂,IC50为2.72 nM,对ALK3的IC50为836 nM。在A549细胞中,它还能抑制TGF-β1诱导的Smad2/3磷酸化,IC50为8.68 nM。 |
||
S7627 |
LDN-214117LDN-214117是一种有效的选择性 BMP I型受体激酶 ALK2 抑制剂,IC50为 24 nM。 |
||
S7959 |
SIS3 HClSIS3是一种新型的特异性Smad3抑制剂,通过抑制Smad3的磷酸化抑制TGF-β和activin信号,而不影响MAPK/p38, ERK或PI3-kinase信号通路。 |
![]() ![]() Cultured cardiac fibroblasts infected with vector lentiviruses or EphrinB2 overexpressing lentiviruses were stimulated with specific antagonist against Stat3 (Stattic, 2.5μM) and/or Smad3 (SIS3, 1μM), respectively. The expression level of α-SMA was quantified via western blotting. In vitro experiments repeat 3 times, *P<0.05, **P<0.01. |
|
S2234 |
BIBF-0775BIBF-0775是transforming growth factor β Receptor I (TGFβRI,Alk5)的选择性抑制剂,IC50为34 nM。 |
||
S8772 |
LY 3200882LY 3200882是有效的、高选择性TGF-β receptor type 1 (TGFβRI)抑制剂,在体外肿瘤组织和免疫细胞以及体内皮下肿瘤中,有效地以浓度依赖方式抑制TGFβ介导的SMAD磷酸化。 |
||
S7530 |
Vactosertib (TEW-7197)Vactosertib (TEW-7197, EW-7197)是一种高效的,选择性的,口服生物有效的TGF-β receptor ALK4/ALK5抑制剂,IC50分别为13 nM 和 11 nM。Phase 1。 |
![]() ![]() Representative immunofluorescent images of HuL6 cells treated with EW-7197, TGF-β1, both, or neither for 72 h. Scale bars, 20 μm.
|
|
S7146 |
DMH1DMH1是选择性BMP receptor抑制剂,抑制ALK2,IC50为107.9 nM,对AMPK, ALK5, KDR (VEGFR-2)和PDGFR没有抑制效果。DMH1可抑制自噬。 |
![]() ![]() The combined treatment with miR-140-5p mimics and some common chemotherapeutics did not have any effect on the SK-MES1 cell line, whereas miR-140-5p and DMH1 and cisplatin decreased the proliferation ofthe A549 cells. Data are presented as mean±SEM of three individual experiments undertaken in triplicate. t-Test was used to assess significance with *p<0.05.
|
|
S7147 |
LDN-212854LDN-212854 (BMP Inhibitor III)是一种强效的选择性BMP receptor抑制剂, 其作用于ALK2的IC50为1.3 nM , 分别超过作用于ALK1, ALK3, ALK4, 和 ALK5的选择性约 2-, 66-, 1641-, 和 7135倍。 |
||
S7148 |
ML347ML347 (LDN-193719) 是一种选择性的BMP receptor抑制剂,其作用于ALK2的IC50为 32 nM ,选择性高于ALK3 300倍。 |
||
S8144 |
HalofuginoneHalofuginone (RU-19110)是脯氨酰-tRNA合成酶(prolyl-tRNA synthetase)的竞争性抑制剂,Ki=18.3 nM。Halofuginone在浓度为10 ng/ml时,可下调哺乳动物细胞中Smad3、抑制TGF-β信号通路。 |
||
S6713 |
ITD-1ITD-1是有效的TGF-β抑制剂。它不抑制TGFBR1或TGFBR的激酶活性,但能够有效地抑制TGFβ2诱导的效应因子SMAD2/3磷酸化,对Activin A的影响甚微。 |
||
S7840 |
Dorsomorphin (Compound C)Dorsomorphin (Compound C, BML-275)是一种有效的,可逆选择性 AMPK 抑制剂,无细胞试验中 Ki 为 109 nM,对几个结构相关的激酶,包括ZAPK,SYK,PKCθ,PKA,和 JAK3没有显著的抑制作用。 也会抑制 I型BMP receptors ALK2,ALK3和ALK6 的活性。Dorsomorphin被应用于促进特定细胞分化和诱导癌细胞自噬。如需进行动物实验,建议选择可水溶产品 S7306 Dorsomorphin (Compound C) 2HCl。 |
![]() ![]() FGF21 activates myogenic and aerobic myofiber-associated genes expression via AMPK pathway. The activator (acadesine) or inhibitor (dorsomorphin) of AMPK pathway were used to treat the pcDNA3.1-21 or control transfected C2C12 myoblasts. For this experiment, four groups were set up: FGF21-ACA (pcDNA3.1-21‡acadesine), Control-ACA (control‡acadesine), FGF21-DOR (pcDNA3.1-21‡dorsomorphin), and Control-DOR(control‡dorsomorphin). The qRT-PCR was performed to detect the genes expression of FGF21 (A), AMPK (B), Sirt 1, Myoglobin(C), Desmin (D), MEF2c (E), a-actin (F). (G) The C2C12 myoblasts were transiently transfected with pCDNA3.1-21 or pCDNA3.1, Western blot showed FGF21 activated AMPK signal via FGF21-Sirt1-AMPK. For the phosphorylated AMPK (right), the intensity of band was normalized total AMPK, and then normalized by control. (H and I) FGF21, as well as AMPK activator acadesine (ACA), increased phosphorylation of AMPM, and myogenic genes expression, especially MyHC I, which was activated by ACA (FGF21‡ACA) and suppressed by AMPK inhibitor DOR(FGF21‡DOR). The data are presented as mean±SD (*P<0.05, **P<0.01, and P<0.001), n=ˆ3. |
|
S6807 |
TA-02TA-02是一种 p38 MAPK 抑制剂,IC50为20 nM。TA-02会特别地抑制 TGFBR-2。 |
||
S5183 |
PD 169316PD 169316 是一种有效的、细胞可渗透的选择性 p38 MAP kinase 抑制剂,IC50值为89 nM。 PD169316 可消除 TGFbeta 和 Activin A 引发的信号传导。 PD169316对 Enterovirus71 具有抗病毒活性。 |
||
S3223 |
L-QuebrachitolL-Quebrachitol (L-QCT) 是可从许多植物中分离出来的天然产物,促进增殖和细胞DNA合成。L-Quebrachitol 可上调 bone morphogenetic protein-2 (BMP-2)、runt-related transcription factor-2 (Runx2) 和 mitogen-activated protein kinase (MAPK) 相关调控基因和 Wnt/β-catenin 信号通路,同时下调 nuclear factor-κB(NF-κB) 配体 (RANKL) 受体激活剂的mRNA水平。 |
||
S7914 |
Isoxazole 9 (ISX-9)Isoxazole 9 (Isx-9)是一种成体神经发生的合成促进剂,通过引起成熟神经干细胞/前体细胞(NSPCs)的神经元分化而发挥作用。Isoxazole 9 (Isx-9) 可激活多条信号通路,包括 TGF-β 诱导的上皮-间质转化信号通路 (EMT) ,以及在心脏分化不同阶段的经典和非经典的 Wnt 信号通路。 |
||
S7658 |
KartogeninKartogenin (KGN)是一种smad4/smad5通路激活剂,促进多功能间充质干细胞选择性分化为软骨细胞。 |
||
S0153 |
SJ000291942SJ000291942 是一种典型的 bone morphogenetic proteins (BMP) 信号通路激活剂。 |
||
S0523 |
SB 4SB 4 是一种 bone morphogenetic protein 4 (BMP4) signaling 的有效的选择性激动剂,其EC50值为74 nM。SB 4可增强经典的BMP信号传导并激活 SMAD-1/5/9 磷酸化。 |
||
S6654 |
SRI-011381SRI-011381是一种新型的TGF-beta信号通路激动剂,用来治疗阿尔茨海默病。 |
||
S2308 |
HesperetinHesperetin是一种生物类黄酮,更具体而言,是一种二氢黄酮。 |
||
S8318 |
AlantolactoneAlantolactone (helenin, helenine, Eupatal),一种天然的桉烷类倍半萜内酯,能诱导activin/SMAD3信号、干扰Cripto-1/activin受体ⅡA型受体的相互作用。 |
![]() ![]() Colon cancer cell lines (A) SW620, (B) HCT116, and (C) HT29 were treated with different concentrations (60, 12, 2.4, 0.48, and 0.098 μM) of nifuroxazide (nifu), niclosamide (nicl), cryptotanshinone (cry), and a lantolactone (ala), respectively, for 72 h. Cell proliferation in each group was detected by MTT assay. (D) HCT116, SW620, and HT29 cell lines were suppressed with niclosamide treatment at different concentrations (20, 10, 5, 2.5, and 1.25 μM) for 72 h. Subsequently, cell proliferation in each group was detected by MTT assay. The data were obtained from 3 independent experiments.
|
目录号 | 产品描述 | 文献引用 | 实验数据 |
---|---|---|---|
S1067 |
SB431542SB431542是一种有效的,选择性ALK5抑制剂,无细胞试验中IC50为94 nM,对ALK5的作用比对p38、MAPK和其他激酶强100倍。 |
![]() ![]() Long-term response of SB431542 and SB203580 release from scaffold implants. Histological results of H&E staining showing the capsule thickness of the various treatments at 14 days. The scale bar shows 100 uM and is applicable to all images in the panel. In each bar graph the tissue and cellular response to SB431542 were found to be significant from the control. For each treatment group six animals were tested. Statistics are performed by ANOVA with Bonferroni comparisons and taken to be significant at ∗∗P < 0.01. |
|
S2618 |
LDN-193189LDN-193189 (DM3189)是一种选择性 BMP 信号抑制剂,抑制 ALK1, ALK2, ALK3和 ALK6,在激酶测定中的 IC50 分别为 0.8 nM、0.8 nM、5.3 nM 和 16.7 nM。LDN-193189 抑制BMP I型受体ALK2和ALK3的转录活性,在C2C12细胞中IC50分别为5 nM和30 nM,作用于BMP比作用于TGF-β选择性高200倍。如需进行动物实验,建议选择可水溶产品 S7507 LDN-193189 2HCl。 |
![]() ![]() LDN induces signifiant cell death. OVCA429 cells were treated with vehicle (DMSO) or experimental drugs for 6 hr to capture different stages of cell death. OVCA429 cell viability was assessed in response to drug treatment for 6 hr by staining with AO (green) and EB (orange). For clarity the different fluorescent channels to detect AO, EB, and the over-lapping images are shown for 10 mM LDN treatment. |
|
S2230 |
Galunisertib (LY2157299)Galunisertib (LY2157299)是有效的TGFβ receptor I (TβRI)抑制剂,无细胞试验中IC50为56 nM。Phase 2/3。 |
![]() ![]() Cells were treated in both formats with 10 uM of SB525334 (TGFβR1), SJN 2511 (TGFβR1), LY2157299 (TGFβR2, TGFβR1), Dorsomorphin (AMPK, ALK2, ALK3, ALK6), DMH-1 (ALK2), or GW5074 (c-raf), or 50 ng/ml of TGF-β. Microtissue or tissue-culture well fluorescence for each condition are shown after 3 days of culture for 393T5 cells, which proliferate slower in control conditions, so that the two cell lines undergo the same number of population doublings during each assay. |
|
S2704 |
LY2109761LY2109761是一种新型的,选择性TGF-β receptor type I/II (TβRI/II)双重抑制剂,无细胞试验中Ki分别为38 nM和300 nM,对Smad2的磷酸化产生负面影响。LY2109761可抑制自噬而诱导凋亡。 |
![]() ![]() The inhibition of TGF-β1 signaling pathways suppressed EBV-mediated EMT, and prevented the activation of Syk and Src signaling. The EBV-infected HCECs were treated with 100 nM of the dual TGF-β receptor I and II kinase inhibitor, LY2109761, for 48 hours. The EBV-infected HCECs were cultured with anti-TGF-β1 neutralizing antibody (5 ug/mL) or mouse IgG1 antibody (5 ug/mL) for 48 hours. Photographs were taken at x100 magnification by a digital camera.
|
|
S1476 |
SB525334SB525334是一种有效的,选择性TGFβ receptor I (ALK5)抑制剂,无细胞试验中IC50为14.3 nM,作用于ALK4比作用于ALK5效果低4倍,对ALK2,3,和 6没有活性。 |
![]() ![]() LS 174T and SW480 cells were treated with SB525334 (1 umol/L) for 12 hours. HMGA2 expression was assessed by immunoblotting. Each experiment was repeated 3 times. Bars, SD; *, P < 0.05; **, P < 0.01.
|
|
S2186 |
SB505124SB505124是一种选择性TGFβR抑制剂,作用于ALK4和ALK5,无细胞试验中IC50分别为129 nM和47 nM,也抑制ALK7,但不抑制ALK1,2,3或6。 |
![]() ![]() (D): Fluorescence micrographs of SOX2/FOXA2 double-staining of the conditions mentioned above. The TGF-b inhibitor SB-505124 (1 mM) was additionally used together with the complete medium. Nuclei were counterstained with DAPI. Original magnification 310 or 340. Abbreviations: DAPI, 40,6-diamidino-2-phenylindole; RA, retinoic acid.
|
|
S7306 |
Dorsomorphin (Compound C) 2HClDorsomorphin 2HCl (BML-275, Compound C) 是一种有效的,可逆的,选择性AMPK抑制剂,在无细胞试验中Ki为109 nM,对一些结构相关的激酶,包括ZAPK, SYK, PKCθ,PKA和JAK3没有显著的抑制作用。也会抑制I型BMP受体。Dorsomorphin 可诱导癌细胞系的自噬。 |
![]() ![]() AMPK inhibition by compound C(Dorsomorphin) inhibited autophagy activation and neuroprotection induced by IPC in PC12 cells. (A) Compound C (Comp C) abolished IPC induced neuroprotection in PC12 cells. Cells were incubated with compound C 5 μM 60 min before the onset of IPC. Twelve hours after IPC, the cells were subjected to OGD for 10 h and cell viability was examined with CCK-8 kit. (B) Compound C reduced LC3II/LC3I ratio. The cells were incubated with compound C 5 μM 60 min before the onset of IPC. Then the cells were harvested 12 h after IPC and subjected to Western blot analysis. Bar represents mean ± SD, n = 3. *P < 0.05, ***P < 0.001 compared with the control group; $$$ P < 0.001 compared with the OGD group; %%% P < 0.001 compared with the IPC + OGD group; # P < 0.05 compared with the IPC group. |
|
S2907 |
Pirfenidone (S-7701)Pirfenidone (S-7701, AMR-69) 抑制TGF-β产生和TGF-β刺激的胶原蛋白产生,且降低TNF-α和IL-1β产生,具有抗纤维化和抗炎特性。Pirfenidone可减弱 chemokine (CC motif) ligand-2 (CCL2) 和 CCL12的生成,并具有抗纤维化的活性。Phase 3。 |
![]() ![]() Ex vivo tissue spotting experiment of pirfenidone dilutions and MalDI imagingn approach of in vivo administered pirfenidone measured with MalDI-TOF mass spectrometer. ex vivo dilution series of pirfenidone (m/z 186.2?.1 Da) covered with CHCa matrix. In vivo treated liver cryosections measured by MalDI-TOF imaging using CHCa. Size bar corresponds to 2 mm.
|
|
S2750 |
GW788388GW788388是一种有效的,选择性ALK5抑制剂,无细胞试验中IC50为18 nM,也抑制TGF-βII型受体和activin II型受体活性,但不抑制BMP II型受体。 |
![]() ![]() Combination treatment with GW788388 and IL-23 aiming to sustain Th17 cell levels increases spleen cell production of the inflammatory mediators IL-17 and TNF-a, the stimulatory mediators IL-2, IFN-g and RANTES, and the inhibitory mediator IL-10. Starting from Week 6 of 4NQO administration, when premalignant oral lesions were detectable on the tongue, mice were initiated on treatment with diluent, GW788388, IL-23 or both GW788388 and IL-23. After 2 months of these treatments, spleens were collected and cultured on anti-CD3 for 3 days. Supernatants were collected and used for measurement of the inflammatory mediators IL-17, TNF-a and IL-6 (a); stimulatory mediators IL-2, IFN-g and RANTES (b); and inhibitory mediators, TGF-b, IL-4 and IL-10 (c). *=p<0.05, **=p<0.01, ***=p<0.001.
|
|
S2805 |
LY364947LY364947 (HTS 466284)是一种有效的ATP竞争性TGFβR-I抑制剂,无细胞试验中IC50为59 nM,比作用于TGFβR-II选择性高7倍。 |
![]() ![]() The cytoplasmic and nuclear proteins were separated and the protein expression levels were determined by performing western blotting. LY364947 (1 uM), which is a potent ATP-competitive inhibitor of TGF-βRI, was used as the positive control. GAPDH and PARP were used as cytosolic and nuclear markers, respectively. |
|
S7223 |
RepSox (E-616452)RepSox (E-616452, SJN 2511, ALK5 Inhibitor II)是一种有效的,选择性TGFβR-1/ALK5抑制剂,作用于ATP与ALK5结合以及ALK5自磷酸化,无细胞试验中IC50分别为23 nM和4 nM。 |
![]() ![]() (C) Generation of pluripotent stem cell from Yamanaka factors-induced OG2-MEFs under treatment of diverse chemical compounds. Images of GFP+ colonies were taken on day 10 post-infection. VPA, 0.5 mmol/L. CHIR99021, 3 μmol/L. Repsox, 1 μmol/L. (D) Quantification of GFP+ colonies in (C). All figures are representative of three independent experiments (n = 3). All data are presented as mean ± SD. *P < 0.05, **P < 0.01 vs. DMSO
|
|
S7507 |
LDN-193189 2HClLDN-193189 (DM3189) 2HCl是一种选择性 BMP 信号抑制剂,抑制 ALK1, ALK2, ALK3和 ALK6,在激酶测定中的 IC50 分别为 0.8 nM、0.8 nM、5.3 nM 和 16.7 nM。LDN-193189 抑制BMP I型受体ALK2和ALK3的转录活性,在C2C12细胞中IC50分别为5 nM和30 nM,作用于BMP比作用于TGF-β选择性高200倍。 |
![]() ![]() LDN induces signifiant cell death. OVCA429 cells were treated with vehicle (DMSO) or experimental drugs for 6 hr to capture different stages of cell death. OVCA429 cell viability was assessed in response to drug treatment for 6 hr by staining with AO (green) and EB (orange). For clarity the different fluorescent channels to detect AO, EB, and the over-lapping images are shown for 10 mM LDN treatment.
|
|
S1576 |
Sulfasalazine (NSC 667219)Sulfasalazine (NSC 667219, Azulfidine, Salazopyrin, Sulphasalazine) 是一种磺胺剂,是Mesalazine的衍生物,主要用作抗炎剂。Sulfasalazine 是一种有效的、特异性的 nuclear factor kappa B (NF-κB)、TGF-β 和 COX-2 的抑制剂。Sulfasalazine 可诱导铁死亡、凋亡和自噬。 |
||
S7359 |
K02288K02288是一种高度选择性I型BMP受体抑制剂,针对 ALK2, ALK1和ALK6的IC50分别为1.1,1.8,6.4 nM,显示对其他ALKS(3,4,5)和的ActRIIa 有轻微抑制作用。 |
![]() ![]() A549 cells were transfected with miR-205 inhibitor (IHT-205, 100 nM). Forty hours after transfection, the cells were seeded on transwell plates and treated with or without inhibitor K02288 (10 nM), AG1478 (1 µM), SB431542 (10 µM) for 10 hours. Migrated cells were quantified. All data are shown as mean± SD. N =3. All experiments have been repeated at least 3times independently. |
|
S7624 |
SD-208SD-208是一种选择性TGF-βRI (ALK5)抑制剂,with IC50为48 nM,选择性比TGF-βRII高100多倍。 |
||
S7692 |
A-83-01A-83-01 是一种有效的 TGF-β type I receptor (ALK5-TD) 的抑制剂,其IC50值为12 nM。A-83-01 还抑制由 activin/nodal type I receptor (ALK4-TD) 和 nodal type I receptor (ALK7-TD) 诱导的转录,对应的IC50值分别为45 nM和7.5 nM。现配现用。 |
||
S0752 |
AUDAAUDA (compound 43) 是一种有效的 soluble epoxide hydrolase (sEH) 的抑制剂,对小鼠sEH和人sEH的IC50值分别为18 nM和69 nM。AUDA具有抗炎活性,可降低MMP-9、IL-1β、TNF-α 和 TGF-β。AUDA还可下调 Smad3 和 p38 信号通路。 |
||
S8700 |
TP0427736 HClTP0427736是一种有效的ALK5 kinase抑制剂,IC50为2.72 nM,对ALK3的IC50为836 nM。在A549细胞中,它还能抑制TGF-β1诱导的Smad2/3磷酸化,IC50为8.68 nM。 |
||
S7627 |
LDN-214117LDN-214117是一种有效的选择性 BMP I型受体激酶 ALK2 抑制剂,IC50为 24 nM。 |
||
S7959 |
SIS3 HClSIS3是一种新型的特异性Smad3抑制剂,通过抑制Smad3的磷酸化抑制TGF-β和activin信号,而不影响MAPK/p38, ERK或PI3-kinase信号通路。 |
![]() ![]() Cultured cardiac fibroblasts infected with vector lentiviruses or EphrinB2 overexpressing lentiviruses were stimulated with specific antagonist against Stat3 (Stattic, 2.5μM) and/or Smad3 (SIS3, 1μM), respectively. The expression level of α-SMA was quantified via western blotting. In vitro experiments repeat 3 times, *P<0.05, **P<0.01. |
|
S2234 |
BIBF-0775BIBF-0775是transforming growth factor β Receptor I (TGFβRI,Alk5)的选择性抑制剂,IC50为34 nM。 |
||
S8772 |
LY 3200882LY 3200882是有效的、高选择性TGF-β receptor type 1 (TGFβRI)抑制剂,在体外肿瘤组织和免疫细胞以及体内皮下肿瘤中,有效地以浓度依赖方式抑制TGFβ介导的SMAD磷酸化。 |
||
S7530 |
Vactosertib (TEW-7197)Vactosertib (TEW-7197, EW-7197)是一种高效的,选择性的,口服生物有效的TGF-β receptor ALK4/ALK5抑制剂,IC50分别为13 nM 和 11 nM。Phase 1。 |
![]() ![]() Representative immunofluorescent images of HuL6 cells treated with EW-7197, TGF-β1, both, or neither for 72 h. Scale bars, 20 μm.
|
|
S7146 |
DMH1DMH1是选择性BMP receptor抑制剂,抑制ALK2,IC50为107.9 nM,对AMPK, ALK5, KDR (VEGFR-2)和PDGFR没有抑制效果。DMH1可抑制自噬。 |
![]() ![]() The combined treatment with miR-140-5p mimics and some common chemotherapeutics did not have any effect on the SK-MES1 cell line, whereas miR-140-5p and DMH1 and cisplatin decreased the proliferation ofthe A549 cells. Data are presented as mean±SEM of three individual experiments undertaken in triplicate. t-Test was used to assess significance with *p<0.05.
|
|
S7147 |
LDN-212854LDN-212854 (BMP Inhibitor III)是一种强效的选择性BMP receptor抑制剂, 其作用于ALK2的IC50为1.3 nM , 分别超过作用于ALK1, ALK3, ALK4, 和 ALK5的选择性约 2-, 66-, 1641-, 和 7135倍。 |
||
S7148 |
ML347ML347 (LDN-193719) 是一种选择性的BMP receptor抑制剂,其作用于ALK2的IC50为 32 nM ,选择性高于ALK3 300倍。 |
||
S8144 |
HalofuginoneHalofuginone (RU-19110)是脯氨酰-tRNA合成酶(prolyl-tRNA synthetase)的竞争性抑制剂,Ki=18.3 nM。Halofuginone在浓度为10 ng/ml时,可下调哺乳动物细胞中Smad3、抑制TGF-β信号通路。 |
||
S6713 |
ITD-1ITD-1是有效的TGF-β抑制剂。它不抑制TGFBR1或TGFBR的激酶活性,但能够有效地抑制TGFβ2诱导的效应因子SMAD2/3磷酸化,对Activin A的影响甚微。 |
||
S7840 |
Dorsomorphin (Compound C)Dorsomorphin (Compound C, BML-275)是一种有效的,可逆选择性 AMPK 抑制剂,无细胞试验中 Ki 为 109 nM,对几个结构相关的激酶,包括ZAPK,SYK,PKCθ,PKA,和 JAK3没有显著的抑制作用。 也会抑制 I型BMP receptors ALK2,ALK3和ALK6 的活性。Dorsomorphin被应用于促进特定细胞分化和诱导癌细胞自噬。如需进行动物实验,建议选择可水溶产品 S7306 Dorsomorphin (Compound C) 2HCl。 |
![]() ![]() FGF21 activates myogenic and aerobic myofiber-associated genes expression via AMPK pathway. The activator (acadesine) or inhibitor (dorsomorphin) of AMPK pathway were used to treat the pcDNA3.1-21 or control transfected C2C12 myoblasts. For this experiment, four groups were set up: FGF21-ACA (pcDNA3.1-21‡acadesine), Control-ACA (control‡acadesine), FGF21-DOR (pcDNA3.1-21‡dorsomorphin), and Control-DOR(control‡dorsomorphin). The qRT-PCR was performed to detect the genes expression of FGF21 (A), AMPK (B), Sirt 1, Myoglobin(C), Desmin (D), MEF2c (E), a-actin (F). (G) The C2C12 myoblasts were transiently transfected with pCDNA3.1-21 or pCDNA3.1, Western blot showed FGF21 activated AMPK signal via FGF21-Sirt1-AMPK. For the phosphorylated AMPK (right), the intensity of band was normalized total AMPK, and then normalized by control. (H and I) FGF21, as well as AMPK activator acadesine (ACA), increased phosphorylation of AMPM, and myogenic genes expression, especially MyHC I, which was activated by ACA (FGF21‡ACA) and suppressed by AMPK inhibitor DOR(FGF21‡DOR). The data are presented as mean±SD (*P<0.05, **P<0.01, and P<0.001), n=ˆ3. |
|
S6807 |
TA-02TA-02是一种 p38 MAPK 抑制剂,IC50为20 nM。TA-02会特别地抑制 TGFBR-2。 |
||
S5183 |
PD 169316PD 169316 是一种有效的、细胞可渗透的选择性 p38 MAP kinase 抑制剂,IC50值为89 nM。 PD169316 可消除 TGFbeta 和 Activin A 引发的信号传导。 PD169316对 Enterovirus71 具有抗病毒活性。 |
目录号 | 产品描述 | 文献引用 | 实验数据 |
---|---|---|---|
S3223 |
L-QuebrachitolL-Quebrachitol (L-QCT) 是可从许多植物中分离出来的天然产物,促进增殖和细胞DNA合成。L-Quebrachitol 可上调 bone morphogenetic protein-2 (BMP-2)、runt-related transcription factor-2 (Runx2) 和 mitogen-activated protein kinase (MAPK) 相关调控基因和 Wnt/β-catenin 信号通路,同时下调 nuclear factor-κB(NF-κB) 配体 (RANKL) 受体激活剂的mRNA水平。 |
||
S7914 |
Isoxazole 9 (ISX-9)Isoxazole 9 (Isx-9)是一种成体神经发生的合成促进剂,通过引起成熟神经干细胞/前体细胞(NSPCs)的神经元分化而发挥作用。Isoxazole 9 (Isx-9) 可激活多条信号通路,包括 TGF-β 诱导的上皮-间质转化信号通路 (EMT) ,以及在心脏分化不同阶段的经典和非经典的 Wnt 信号通路。 |
||
S7658 |
KartogeninKartogenin (KGN)是一种smad4/smad5通路激活剂,促进多功能间充质干细胞选择性分化为软骨细胞。 |
||
S0153 |
SJ000291942SJ000291942 是一种典型的 bone morphogenetic proteins (BMP) 信号通路激活剂。 |
目录号 | 产品描述 | 文献引用 | 实验数据 |
---|---|---|---|
S0523 |
SB 4SB 4 是一种 bone morphogenetic protein 4 (BMP4) signaling 的有效的选择性激动剂,其EC50值为74 nM。SB 4可增强经典的BMP信号传导并激活 SMAD-1/5/9 磷酸化。 |
||
S6654 |
SRI-011381SRI-011381是一种新型的TGF-beta信号通路激动剂,用来治疗阿尔茨海默病。 |
目录号 | 产品描述 | 文献引用 | 实验数据 |
---|---|---|---|
S2308 |
HesperetinHesperetin是一种生物类黄酮,更具体而言,是一种二氢黄酮。 |
||
S8318 |
AlantolactoneAlantolactone (helenin, helenine, Eupatal),一种天然的桉烷类倍半萜内酯,能诱导activin/SMAD3信号、干扰Cripto-1/activin受体ⅡA型受体的相互作用。 |
![]() ![]() Colon cancer cell lines (A) SW620, (B) HCT116, and (C) HT29 were treated with different concentrations (60, 12, 2.4, 0.48, and 0.098 μM) of nifuroxazide (nifu), niclosamide (nicl), cryptotanshinone (cry), and a lantolactone (ala), respectively, for 72 h. Cell proliferation in each group was detected by MTT assay. (D) HCT116, SW620, and HT29 cell lines were suppressed with niclosamide treatment at different concentrations (20, 10, 5, 2.5, and 1.25 μM) for 72 h. Subsequently, cell proliferation in each group was detected by MTT assay. The data were obtained from 3 independent experiments.
|